RED CELL DISTRIBUTION WIDTH DECREASED

This adverse event was reported 0 times

These drugs are most commonly taken by patients reporting RED CELL DISTRIBUTION WIDTH DECREASED:

# Drug Count
0 METHOTREXATE SODIUM 113
1 ADALIMUMAB 111
2 ETANERCEPT 106
3 TOCILIZUMAB 106
4 LEFLUNOMIDE 105
5 ABATACEPT 104
6 INFLIXIMAB 103
7 SULFASALAZINE 103
8 METHOTREXATE 101
9 RITUXIMAB 98
See all common drugs associated with RED CELL DISTRIBUTION WIDTH DECREASED

RED CELL DISTRIBUTION WIDTH DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIMENHYDRINATE 43 0.0040
1 EMPAGLIFLOZIN AND LINAGLIPTIN 7 0.0036
2 ALEMTUZUMAB 63 0.0033
3 DEFLAZACORT 8 0.0031
4 AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE 2 0.0031
5 DICLOFENAC POTASSIUM 28 0.0025
6 CORTISOL 1 0.0025
7 CALCIUM GLUCONATE 28 0.0023
8 BARIUM SULFATE 1 0.0023
9 CORTISONE ACETATE 28 0.0022
See all drugs enriched for association with RED CELL DISTRIBUTION WIDTH DECREASED

RED CELL DISTRIBUTION WIDTH DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 63 0.0033
1 Diagnostic Dye [EPC] 1 0.0015
2 Aminosalicylate [EPC] 103 0.0010
3 Antirheumatic Agent [EPC] 105 0.0010
4 Interleukin-6 Receptor Antagonist [EPC] 106 0.0008
5 Selective T Cell Costimulation Modulator [EPC] 104 0.0007
6 alpha-Hydroxy Acid [EPC] 1 0.0005
7 Bismuth [EPC] 2 0.0004
8 CD20-directed Cytolytic Antibody [EPC] 103 0.0003
9 Plasma Volume Expander [EPC] 1 0.0003
See all drug classes enriched for association with RED CELL DISTRIBUTION WIDTH DECREASED